(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...
Dates are a popular snack, known for their natural sweetness, rich flavor, and chewy texture. These small fruits are often ...